What did @ifbbama actually say?
James Hollingshead laid out a post-competition protocol covering training, nutrition, and what he called "the drugs" used around a show. On the supplement side, he recommended saw palmetto for prostate protection, "stragglers" (likely astragalus) for kidney support, NAC for liver health, ubiquinol for heart health, and vitamin D3/K2 as general support. His position: "just because the drugs are out, doesn't mean you still don't need protection." On training, he advised cutting volume post-show. On nutrition, he suggested reintroducing fats across multiple meals, especially first and last meal of the day.
This is a harm-reduction framing aimed at competitive bodybuilders who are already using anabolic compounds. He is not selling these supplements as cures. He is presenting a recovery logic: organ support does not stop being relevant the moment a competition cycle ends.
Does the science back this up?
Partially, and some of it more than you might expect from a bodybuilding podcast. The saw palmetto recommendation for prostate health has modest but real evidence behind it. Astragalus has some preclinical kidney-protective data, though human trials are limited. NAC for liver support is well-documented. Ubiquinol for cardiac function has legitimate mechanistic backing.
NAC (N-acetylcysteine) is probably the strongest call here. It is a precursor to glutathione, and its hepatoprotective properties are documented in multiple clinical contexts, including drug-induced liver injury (Mokhtari et al., 2017, European Journal of Pharmacology). Ubiquinol is the reduced, more bioavailable form of CoQ10. Research by Mortensen et al. (2014, JACC Heart Failure) found CoQ10 supplementation reduced major cardiac events in chronic heart failure patients. That is a different population than healthy bodybuilders, but the mechanistic rationale for using it during periods of cardiovascular stress is not unreasonable. Vitamin D3/K2 co-administration is supported by evidence that K2 helps direct calcium appropriately and may reduce arterial calcification risk (Geleijnse et al., 2004, Journal of Nutrition).
What did they get wrong (or right)?
The organ-support logic is directionally correct, and frankly, it is better harm-reduction messaging than most bodybuilding content. But the astragalus kidney claim is the weakest link. Human evidence for astragalus as a kidney protectant is sparse and mostly limited to traditional medicine literature and small studies in chronic kidney disease patients, not healthy people recovering from diuretic or compound use (Zhang et al., 2014, Journal of Ethnopharmacology). Extrapolating that to post-contest recovery is a stretch.
The prostate recommendation via saw palmetto is also more complicated than stated. A Cochrane review (Tacklind et al., 2012) found saw palmetto did not improve urinary symptoms better than placebo in men with benign prostatic hyperplasia. Its use as a preventive measure in younger bodybuilders using androgens has even less direct evidence. The logic is not crazy, but the evidence does not firmly support it.
What he got right: reducing training volume post-show. Post-contest fatigue involves more than tired muscles. Hormonal suppression, metabolic adaptation, and psychological burnout all converge after a prep. Pushing volume at that point is a genuine recovery mistake.
What should you actually know?
If you are not a competitive bodybuilder using anabolic compounds, most of this protocol is not directly relevant to you. If you are using testosterone under medical supervision through a licensed TRT program, the organ-support framing still has some relevance, particularly NAC and CoQ10, but the clinical context is very different from a competitive prep cycle.
The bigger issue this video does not address is that post-competition hormonal crashes are serious. Natural testosterone suppression after anabolic compound use can last months and is associated with depression, fatigue, and loss of libido. That is not a supplement problem. It is a medical situation that requires oversight from a physician who understands endocrinology, not a podcast protocol.
Organ support supplements are not substitutes for blood work. AST, ALT, creatinine, and testosterone panels before and after a cycle tell you what is actually happening. No supplement stack replaces that data.
Bottom line: is this worth listening to?
For its intended audience, this is more responsible than average. Hollingshead is not recommending reckless behavior. He is telling experienced competitors to maintain basic support protocols and reduce training load post-show. That is reasonable advice. The specific supplement claims range from well-supported (NAC, ubiquinol) to weakly evidenced (astragalus, saw palmetto). Anyone applying this to a medically supervised TRT context should discuss supplement additions with their prescribing provider, not self-stack based on podcast recommendations.